Chondrosarcoma diagnostic study of choice

Revision as of 15:16, 23 January 2019 by Rohan Bhimani (talk | contribs)
Jump to navigation Jump to search

Chondrosarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chondrosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chondrosarcoma diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chondrosarcoma diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chondrosarcoma diagnostic study of choice

CDC on Chondrosarcoma diagnostic study of choice

Chondrosarcoma diagnostic study of choice in the news

Blogs on Chondrosarcoma diagnostic study of choice

Directions to Hospitals Treating Chondrosarcoma

Risk calculators and risk factors for Chondrosarcoma diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Diagnostic Study of Choice

Study of choice

  • Biopsy is the gold standard test for the diagnosis of chondrosarcoma.

Technique

  • Open
  • Closed

Open Technique

  • The tumor is surgically exposed and biospy of the tumor is taken.

Incision

  • Longitudinal incision in the extremities is taken.
  • It should allow for extension of the incision for definitive management

Approach

  • Never expose neurovascular structures.
  • During the biopsy, all tissue exposed is considered contaminated with tumor.
  • Meticulous hemostasis to be carried out.
  • Post-surgery hematomas are considered contaminated with tumor.
  • Always deflate the tourniquet prior to wound closure.

Biopsy

  • Perform through the involved compartment of the tumor.
  • For bone lesions with a soft tissue mass, perform the biopsy using the soft tissue mass.

'Closure

  • If drain is kept, remove the drain out of the skin in line with surgical incision.
  • This helps in excising the drain site with definitive surgical extensile incision.

Closed Technique

Diagnostic results

The following finding(s) on performing [investigation name] is(are) confirmatory for [disease name]:

  • [Finding 1]
  • [Finding 2]
Sequence of Diagnostic Studies

The various investigations must be performed in the following order:

  • X-ray
  • MRI
  • Biopsy

Enneking (MSTS) Staging System

  • The Enneking surgical staging system (also known as the MSTS system) for malignant musculoskeletal tumors based on histological and radiographic characteristics of the tumor host margin.[1][2]
  • It is widely accepted and routinely used staging system.
Stages Grade Site Metastasis
IA G1: Low grade T1: Intracompartmental M0: No metastasis
IB G1: Low grade T2: Extracompartmental M0: No metastasis
IIA G2: High grade T1: Intracompartmental M0: No metastasis
IIB G2: High grade T2: Extracompartmental M0: No metastasis
III G1 or G2 T1 or T2 M1: Regional or distant metastasis

References

  1. Jawad MU, Scully SP (2010). "In brief: classifications in brief: enneking classification: benign and malignant tumors of the musculoskeletal system". Clin Orthop Relat Res. 468 (7): 2000–2. doi:10.1007/s11999-010-1315-7. PMC 2882012. PMID 20333492.
  2. Peabody, Terrance (2014). Orthopaedic oncology : primary and metastatic tumors of the skeletal system. Cham: Springer. ISBN 9783319073224.

Template:WH Template:WS